While the legality of cannabis for medical and recreational purposes is still being debated in local, state, and federal governments, the benefits of other products derived from cannabis are starting to develop such as cannabidiol known as CBD.
Being a relatively new industry merchants selling this new and legally limboed product are considered High-Risk in the same category as pharmaceuticals. Requiring the same services needed to process regular chargebacks and legal suits.
